Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.57 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.41 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | IAPP | P10997 | 3/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | DDO | Q99489 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2914268 | 0.86 | ALOX5 (0.46) | GABRA1GABRB2CA2SHBGIAPP | |
| SCHEMBL1833403 | 0.86 | CA2 (0.56) | GABRA1GABRB2CA2SHBGCYP3A4 | |
| SCHEMBL56747 | 0.85 | GABRA1 (0.61) | GABRA1GABRB2CA2HSPA5ATM | |
| SCHEMBL3216750 | 0.81 | CA2 (0.45) | GABRA1GABRB2CA2SHBGATM | |
| SCHEMBL2914642 | 0.81 | GABRA1 (0.52) | GABRA1GABRB2CA2IAPPALOX5 | |
| SCHEMBL9577895 | 0.80 | GABRA1 (0.67) | GABRA1GABRB2CA2HSPA5ATM | |
| SCHEMBL57139 | 0.80 | GABRA1 (0.67) | GABRA1GABRB2CA2HSPA5ATM | |
| SCHEMBL11603727 | 0.80 | CA2 (0.41) | GABRA1GABRB2CA2SHBGCYP3A4 | |
| SCHEMBL2911405 | 0.79 | GABRA1 (0.62) | GABRA1GABRB2CA2SHBGATM | |
| SCHEMBL18767597 | 0.79 | CA2 (0.43) | GABRA1GABRB2CA2SHBGRIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2110370-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-1348686-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-03-03 | — | — | EP | disclosed |
| EP-2110370-A1 | Method of producing p-hydroxyphenylalkanols | Sumitomo Chemical Company, Limited (JP) | 2009-10-21 | — | — | EP | disclosed |
| US-6717020-B2 | HIGH YIELD REACTION OF PHENOLS AND UNSATURATED ALCOHOLS IN PRESENCE OF SUCH AS TITANIUM TETRAETHOXIDE AND SODIUM METHOXIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-04-06 | — | — | US | disclosed |
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-10-16 | — | — | US | disclosed |
| EP-1348686-A1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | ADH1C, NR1H3, ADH5 | GABRA1 4187/4885GABRB2 4176/4885CA2 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.